Document Detail

Effectiveness of vitamin E for treatment of long-term tardive dyskinesia.
MedLine Citation:
PMID:  8185007     Owner:  NLM     Status:  MEDLINE    
Eleven patients with tardive dyskinesia were treated in a double-blind study of vitamin E or placebo for 12 weeks. Abnormal Involuntary Movement Scale (AIMS) ratings were performed before and after treatment. Patients receiving vitamin E showed a significant reduction in their AIMS scale score, but patients receiving placebo showed no significant change. Vitamin E had a helpful effect even for patients whose tardive dyskinesia was mild and long-term.
L M Dabiri; D Pasta; J K Darby; D Mosbacher
Related Documents :
7517477 - An evaluation of patients with severe intermittent claudication and the effect of treat...
3094627 - Does short term placebo treatment of chronic schizophrenia produce long term harm?
8185007 - Effectiveness of vitamin e for treatment of long-term tardive dyskinesia.
1435847 - A double-blind trial of 1% ketoconazole shampoo versus placebo in the treatment of dand...
11197587 - Neuraminidase inhibitors: zanamivir and oseltamivir.
18612807 - The association between anxiety sensitivity and atopy in adult asthmatics.
Publication Detail:
Type:  Clinical Trial; Journal Article; Randomized Controlled Trial    
Journal Detail:
Title:  The American journal of psychiatry     Volume:  151     ISSN:  0002-953X     ISO Abbreviation:  Am J Psychiatry     Publication Date:  1994 Jun 
Date Detail:
Created Date:  1994-06-15     Completed Date:  1994-06-15     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  0370512     Medline TA:  Am J Psychiatry     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  925-6     Citation Subset:  AIM; IM    
Department of Psychiatry, San Mateo County Mental Health Services, Calif.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Ambulatory Care
Double-Blind Method
Dyskinesia, Drug-Induced / diagnosis,  drug therapy*
Middle Aged
Physical Examination
Severity of Illness Index
Vitamin E / therapeutic use*
Reg. No./Substance:
0/Placebos; 1406-18-4/Vitamin E

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  No relation between risk of schizophrenia and prenatal exposure to influenza in Holland.
Next Document:  Childhood separation anxiety disorder in patients with adult anxiety disorders.